Recall batches of Glyxambi 25mg/5mg film-coated tablets
2024-12-08
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Glyxambi 25mg/5mg film-coated tablets EMPAGLIFLOZIN, LINAGLIPTIN 118-68-18 205078 205080 206825 401650 Boehringer Ingelheim Pharma GmbH & Co. KG
التصنيف
ملف
التاريخ
2024-10-30
اسم المستحضر
Glyxambi 25mg/5mg film-coated tablets
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
Saudi FDA issued a recall of the mentioned batches of Glyxambi 25mg/5mg film-coated tablets due to a printing error of (empagliflozin) concentration on the outside packaging. Boehringer Ingelheim Pharma is voluntarily recalling the affected batches on the warehouse level only.
التوصيات
For healthcare professionals, this is a notification about the voluntary recall no action is required as the product quality is not impacted.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.